Utilization and Health Outcomes for Veterans with Expanded Health Care Accessâ¯
Utilization and Health Outcomes for Veterans with Expanded Health Care Accessâ¯
批准号:
10221782
负责人:
TODD H WAGNER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
AffectAgeAutomobile DrivingBudgetsCaringCensusesCommunitiesCommunity HealthcareCorrelation StudiesDataDiagnosisDiseaseElderlyEligibility DeterminationEnsureEtiologyEvolutionFutureGeneral PopulationHealthHealth InsuranceHealth PersonnelHealth Services AccessibilityHealth Services ResearchHealthcareHealthcare SystemsImprove AccessIndividualInsurance CoverageInvestmentsLinkLocationMachine LearningMeasuresMedicareMethodologyMethodsNatural experimentOutcomePatientsPersonsPoliciesPrevalencePrivatizationProceduresProviderPublishingQuality of CareRecordsResearchResearch MethodologySeminalServicesSubgroupSurveysSystemTechniquesTestingTimeVeteransWait TimeWorkdesigneconometricsevidence basegaps in accesshealth care availabilityhealth care service utilizationimprovedinnovationmortalitynovelprogramsrandomized, clinical trialssatisfactiontreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: Improving access to high-quality care is a top priority for VHA. However, access is difficult to
measure, especially in the ever-changing U.S. health care landscape. VHA currently focuses on perceived
satisfaction measured from survey questions, or wait times measured with administrative data. The wait time
metric has received considerable focus in both the Choice and MISSION Acts, yet experts recognize that wait
times are imperfect; they are not only challenging to interpret, but they are rarely available from community
providers, hindering any VHA to non-VA comparisons. VHA leaders tasked with implementing the Choice and
MISSION Acts desire better evidence-based access measures so they can evaluate their program’s impact.
Our inability to measure access threatens the future of VHA as a health care provider. Without new metrics
that track gaps or improvements in access, VHA is likely to invest in the wrong initiatives, fueling critics who will
argue that privatization will fix the programs Significance/Impact: Our objective is to develop new measures
of access. These new measures will provide causal information on gaps in VHA services, while also showing
the potential impact that expanded access would have on Veterans’ health. Our study leverages natural
experiments in the form of arbitrary administrative rules that enable Veterans to access care outside VHA in
the forms of Medicare and VA Community Care (VACC). Veterans close to the rule thresholds are similar, yet
some gain access based on the rule, while the others do not. We can leverage this information to understand
how this added access changes health care utilization and health outcomes. Our results will be useful to
national and local VHA leaders as they grapple with how to best improve access with a limited budget.
Innovation: It is not feasible to perform a large-scale randomized clinical trial to find the effect of access on
utilization and health outcomes. Correlational studies will miss important confounders, and as everyone knows
correlation does not equal causation, which is what VHA leaders need most. Instead, we apply novel
econometric techniques to take advantage of natural experiments and find the causal effects of increasing
access. The results from this approach can then be used as a measure of access for both VHA and non-VA
care. This is directly aligned with HSR&D's priorities on access to care, research related to the MISSION Act,
and advancing health services research methods across conditions or care settings. Specific Aims: Aim 1:
Find the causal impact of Medicare eligibility on Veteran utilization and health, and identify procedures and
diagnosis groups that are most affected. Aim 2: Find the causal impact of VACC on Veteran utilization and
health, and find the procedures and diagnoses most affected. Aim 3: Identify subgroup analyses that would
give crucial information to VHA leaders. Methodology: In Aims 1 and 2, we will apply an econometric
technique called regression discontinuity design. We will gather a near complete census of VHA and non-VA
records for all recent Veteran VHA users, allowing for precise claims-based measures of utilization, health, and
mortality. In Aim 1, this approach leverages the sharp change in Medicare eligibility that occurs at age 65 to
find the effect of Medicare on utilization and health. Aim 2 uses the same approach, but instead of age 65, we
use the driving distance rules to find the effect of VA Community Care on utilization and health. For these aims
we will examine both overall effects and procedure and diagnosis specific effects. In Aim 3, we take a
combined approach of working with operational partners and applying machine learning techniques for
heterogenous treatment effects to identify and examine metrics and measures that can be used for policy
formation. Next Steps and Implementation: By working with operational partners through Aim 3, we will
identify opportunities and barriers to implementing measures and metrics derived from our results. This
information will be key to setting policy related to VHA’s evolution into a provider and payer of Veteran care
while ensuring that Veterans receive high-quality care in both VHA and non-VA settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Utilization and Health Outcomes for Veterans with Expanded Health Care Accessâ¯
-
批准号:10844340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:TODD H WAGNER
-
依托单位:
Access to Specialty Care for Veterans with Complex Conditions
-
批准号:9768328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:TODD H WAGNER
-
依托单位:
Access to Specialty Care for Veterans with Complex Conditions
-
批准号:8865960
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:TODD H WAGNER
-
依托单位:
Access to Specialty Care for Veterans with Complex Conditions
-
批准号:9064715
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:TODD H WAGNER
-
依托单位:
THE USE AND EFFECTS OF HEALTH INFORMATION
-
批准号:2806218
-
项目类别:
-
资助金额:$2.71万
-
财政年份:1998
-
负责人:TODD H WAGNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: